1. Ingrezza is the first and only FDA-approved medication specifically designed to treat the involuntary movements, or chorea, associated with Huntington's disease.
2. Ingrezza works by targeting the neurotransmitter dopamine in the brain, which is believed to play a key role in the development of chorea symptoms.
3. Ingrezza is taken in capsule form once daily, with or without food.
4. Common side effects of Ingrezza may include drowsiness, tiredness, and a feeling of restlessness.
5. It's important to follow your doctor's instructions carefully when taking Ingrezza, as the dosage may need to be adjusted over time.
6. Ingrezza has been shown to significantly reduce chorea symptoms in patients with Huntington's disease, improving overall quality of life.
7. Ingrezza may interact with certain medications, so be sure to inform your doctor of all medications you are currently taking before starting treatment.
8. Ingrezza is not recommended for use in pregnant women, as it may harm the developing fetus.
9. If you experience any severe or persistent side effects while taking Ingrezza, be sure to contact your doctor immediately.
10. Ingrezza represents a significant breakthrough in the treatment of Huntington's disease chorea, offering hope to patients and their families for a better quality of life.